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CHAPTER 1: Background
1.1 Introduction
1.1.1 Protein post-translational modification
Protein post-translational modification (PTM) raises the functional variety of the
proteome. Depending on the specific way of protein modification, such as extra bonding of
function groups or proteolytic cleavage of subunits, it can be classified into phosphorylation,
glycosylation, nitrosylation, ubiquitination, lipidation, acetylation, methylation, and
proteolysis. Well understanding and identifying PTMs are important in the study of cell
biology and disease treatment as these modifications impact almost every sides of
pathogenesis and microbiology.
Protein methylation is a process that is transferring a one-carbon methyl group to an
amino acid side chain of the protein. This transfer usually occurs on lysine or arginine,
conjugating one, two or three methyl groups to residues. When methyl group bound to
carboxylic acids, methylation neutralizes a negative amino acid charge and improves the
hydrophobicity of protein. S-adenosyl methionine (SAM) is the primary methyl group donor,
which has been suggested to be the second common used substrate in enzymatic reaction.
Lysine methylation is also a well-known machinery of epigenetic regulation, since
histone lysine methylation and demethylation effects the transcriptional accessibility of DNA.
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1.1.1.1

Non-histone Protein Lysine Methylation

Figure 1:the catalysis of the methyl transfer from co-factor S-Adenosyl-Lmethionine
(AdoMet) to the ε-amine of the lysine residue (1)

However, comparing to histone methylation, people are just getting to know nonhistone methylation. The first reported event of non-histone protein methylation was monomethylation of p53 protein by SET7 (2). Beside of protein p53, several other non-histone
proteins have been studied as well. Most of those proteins are either histone-/DNA-modifying
enzymes, like KMT1C and DNMT1, or transcriptional factors, like RB, E2F1, NFκB(3).
Methylation of lysine residues (Figure 1) on non-histone proteins has occurred as an
important regulator of cellular signaling transduction that mediated by several signaling
pathways, such as BMP, Hippo, JAK–STAT, MAPK, and WNT. Crosstalk between nonhistone protein and histone methylation, and between methylation and other kinds of posttranslational modifications, constantly emerges and affects biochemical cellular functions
including chromatin remodeling, DNA repair, gene transcription, signal transduction and
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protein synthesis. With recent progress in proteomic research and particular mass
spectrometry, the stage is set to reveal the methylproteome and define its functions in health
and disease.(4)

1.1.2 Epigenetic regulation
Epigenetic regulation consists of 3 highly interconnected epigenetic pathways: DNA
methylation, histone translational modifications, and RNA modification, impacting on the
chromatin structure and accessibility. Understanding the term of epigenetics requires a
comprehension of chromatin structure. Chromatin, formed by repeating units called
nucleosomes, which is a complex of protein and DNA/RNAs (5). A nucleosome are made up
of double-stranded DNA wrapping around histone proteins, which is an octamer consists of
two copies of each core histones H2A, H2B, H3, and H4. DNA can be chemically modified
with epigenetic marks that affect the structure of chromatin by changing the affinity of
interactions with proteins which bind to chromatin and by the chromatin electrostatic nature
altering.
Comparing to DNA modification, histone modification is more dynamic. Histones are
subjects to a few different covalent modifications, such as acetylation, methylation,
sumoylation, phosphorylation and ubiquitination(Figure 2). Histone modifications could have
diverse influences based on the location and type of modification on the histone. The bestidentified histone modifications are acetylation and methylation. The enzymes that methylate
histone are called histone methyltransferases. Histone methylation plays a vital role in
transcriptional regulation, could be either suppressive or simulative, according to the location
of the methylated residue. Methylation of the lysine at the fourth residue of histone H3
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(H3K4me), for example, facilitates a transcriptionally active conformation, as opposite to
H3K4me, where at the ninth lysine, H3K9me inhibit a transcriptionally conformation.
Furthermore, H3K36me can be either suppressive or simulative, depending on proximity to a
gene promoter region.

Figure 2: Histone lysine modification(6)

1.1.2.1

Histone Lysine Methylation

As this figure above, lysine is the majority of histone modification substrate. Lysine
methylation is a covalent protein post-translational modification (PTM) that modulates a
myriad of biological processes. The presence of this PTM on histone alters chromatin
structure and function, which is involved in the regulation of DNA damage response,
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transcription activity and cell cycle progression (5). Difficult to characterize in itself,
methylation complexity also increases from the potential of mono-, di-, or tri- methylation
of lysine side chain, producing multiple states for the single modification(7).
The lysine methylation was identified to be localized on histone proteins in 1964 (8). While
sites of methylation on histones were verified, the biological function of the histone
methylation remained unknown. The biological consequence of the methylation of lysine
residues on histones and the influences on genetic expression were first discovered through
the formation of heterochromatin-mediated by the recruitment of HP1 to the H3K9 methyl
mark (9), raising interest in lysine methylation on epigenetic regulation.

1.1.3 Lysine Methyltransferases
Lysine methyltransferases (KMTs) catalyze methylation by transferring one, two,
or three methyl groups, from SAM to the ε-amino group of a lysine residue. Except for
KMT4/DOT1L, all known KMTs are consist of a conserved SET (Su(var)3-9, Enhancer of
Zeste, Trithorax) domain with the enzymatic activity (10). Besides the SET domain, most
KMTs also have some other defined protein domain or homologous sequence to classify
KMTs into distinct subfamilies (11). Naming enzymes were based on their relationship in
sequence and domain structure, including the catalytic domain (Figure 3).The majority of
KMT3 family focused on methylation of H3K36, whereas some SMYD proteins were
observed to methylate H3K4 and other residues.
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Figure 3: Human KMTs and their histone and non-histone substrates(12)
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1.2 SMYD protein family
The SMYD (SET and MYND domain) family proteins, which are a special group of
protein lysine methyltransferases participated in methylation of histones and non-histone
targets, plays pivotal roles in numerous cellular processes including gene expression
regulation and DNA damage response(13).
So far, SMYD family has five members, SMYD1–5(Figure 4)(14). Each member
contains a conserved SET (Suppressor of variegation, Enhancer of Zeste, Trithorax) domain
interrupted by an MYND (Myeloid-Nervy-DEAF1) domain(15). The SET domain, which is
approximately 130 amino acid long, is a conserved catalytic unit responsible for lysine
methylation and found in nearly all histone methyltransferase(16). The MYND domain is a
zinc finger motif that basically functions as a protein–protein interaction module(17,18) and
has been suggested that has a preference for binding with a proline-rich motif (PXLXP) in the

Figure 4: Overall structure of SMYD) proteins.(19)
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interaction with other protein(20). The last feature is the TPR (Tetratrico Peptide Repeat)
domain found in SMYD1–4 but not in SMYD5, which are important for the modulation of
protein-protein interactions, and SMYD4 contains an additional TPR domain at its Nterminus.

1.2.1 SMYD protein sequence analysis
As shown in (Figure 4), the structures of SMYD proteins share a lot of commons.
However, according to the alignment of the protein sequence of SMYD proteins, the percent
identity of two SMYD protein (homo sapiens) members is approximately 20%-30% (Table
1), indicate the SMYD proteins are diverse in metazoans. So, to understand the history of

evolutionary and functional conservation or diversification, a critical phylogenetic
reconstruction of this complicated gene family is significant. The study of phylogenetic tree
analysis of SMYD protein sequences has been started, and the results indicate that the existing
metazoan SMYD genes turned into three main classes, SMYD4, SMYD5 and SMYD3
(including chordate-specific SMYD1, SMYD2 genes). SMYD1 and SMYD2, which are most
close to each other in this five members, are most similar to SMYD3. The reason SMYD1
and SMYD2 are under SMYD3 class is they are respectively exclusive of chordates and
vertebrates but SMYD3 exist in all species of metazoans. The evolutionary of the SMYD3
class and SMYD5 class is relatively simple. However, the SMYD4 class has passed through
a few events such as gene duplication, gene loss, and lineage-specific expansions in the animal
phyla. SMYD4 gene has dupicated into more sub-group but they are not redundant since four
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SMYD4 genes in Drosophila melanogaster are expressed different patterns and deletion of
individual genes behave diverse phenotypes (21).
Table 1: SMYD Proteins Percent Identity Matrix. According to protein sequence alignment of
SMYD family, this table shows percent identity between two SMYD proteins.
"100" - 100% identity.

SMYD5 SMYD4 SMYD1 SMYD3 SMYD2

1: SMYD1

25.10 20.86 100.00 31.12 30.61

2: SMYD2

27.86 21.81 30.61 32.37 100.00

3: SMYD3

26.09 23.35 31.12 100.00 32.37

4: SMYD4

22.95 100.00 20.86 23.35 21.81

5: SMYD5

100.00 22.95 25.10 26.09 27.86

1.2.2 SMYD family function in biological development
The SMYD family members SMYD1-4 are required in critical developmental
processes, especially related to cardiac and muscle development.
SMYD1 is essential for heart development via cardiomyocyte differentiation and
maturation(22) and its expression in the heart is directed by myocyte enhancer factor-2c
(MEF2C)(23) and serum response factor (SRF)(24). In skeletal muscle cells, its transcription
is regulated by myogenic differentiation antigen 1 (MYOD)(25). SMYD1 is expressed during
the growth of zebrafish and is necessary for proper development of skeletal muscle, myofibril
organization and muscle contraction(26), as well as sarcomerogenesis.
Additionally, SMYD2 is expressed in cardiac muscle as well during cardiogenesis
(27) and both SMYD1 and SMYD2 enzymes are expressed during muscle development in
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Xenopus laevis (28). SMYD2 is also reported to methylate HSP90 and altered chick muscle
functions(29).
In zebrafish, SMYD3 is vital in heart and trunk muscle development. Knockdown
of SMYD3 ends up in abnormal expression of heart chamber markers and myogenic
regulatory factors(30).
The knockdown of SMYD4 in embryos of Drosophila cause 80% of knockdown
flies remained trapped in the pupal case and died during the eclosion stage. Eclosion
requires movement of the abdominal muscles to make flies be able to escape from the case.
Suggesting that s4 is likely to play a role in controlling muscle development(31).
However, SMYD5 is not required for heart and skeletal muscle development.
Recent research suggests that SMYD5 plays an important role in hematopoiesis(32).
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1.2.3 SMYD family methylate histone and non-histone protein

SMYD proteins methylate a diverse group of histone and non-histone proteins that
contribute to their critical roles in cell regulation such as chromatin remodeling, transcription,
signal transduction, and cell cycle control. Methylation substrates of SMYD family members
are summarized in the following table (Table 2).
Table 2: Summary of known substrates for the SMYD family of methyltransferases.(20,33)

Enzyme name

Substrate
Histone
Non-histone

SMYD1

H3K4

Myosin, skNAC
HSP90

SMYD2

H3K4
H3K36

p53, RB1, PARP1,
ERα HSP90

SMYD3

H3K4
H4K5

VEGFR1
MAP3K2
HSP90

SMYD4

?

?

SMYD5

H4K20

?
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1.3 SMYD5
1.3.1 SMYD5 methylate H4K20
According to a recent report, histone H4 lysine 20 (H4K20) can be trimethylated
by SMYD5(34). Associated with NcoR chromatin remodeling complexes, the methylation
represses the inflammatory response through restricting of toll-like receptor 4 (TLR-4)
mediated expression in mouse primary macrophages. Removal of H4k20me3 by PHF2 can
activate the expression (Figure 5).

Figure 5: Role of H4K20me3 in the regulation of TLR4-responsive genes.(34)

However, the roles of this repressive histone modification in biological
development and pluripotency are largely elusive.
Epigenetic regulations of chromatin states are assumed that involved in the selfrenewal and differentiation of embryonic stem (ES) cells. The latest study showed that the
histone lysine methyltransferase SMYD5 regulates ES cell self-renewal, alters cell
differentiation (35).
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Knockdown of SMYD5 leads to ES cell colony morphology abnormality, where
shSmyd5 ES cell colonies became flat and scattered and lost contacting between cells at
the colony periphery (Figure 6). Also, deletion of SMYD5 results in dysregulate expression
of pluripotency regulators OCT4 targets, and disturbed ES cell differentiation.

Figure 6: Bright-field microscopy of ES cells infected with shLuc or shSmyd5 lentiviral
particles and wild-type (WT) SMYD5 or an enzymatically mutant (mut) version of SMYD5
(H315L and C317A) lentiviral particles and stably selected with puromycin and
G418.(35)

This paper also reported that SMYD5 regulates H4K20me3 modification at
heterochromatin in ES cells.
Heterochromatin is a tightly packed formation of DNA and localizes at the
periphery of the nucleus. It was thought inaccessible of polymerases and not transcribed.
However, since 2007, many studies have demonstrated that it is actually transcribed into
noncoding RNA molecules containing telomeric and subtelomeric sequences(36).
Heterochromatin plays an essential role in gene expression during development and
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differentiation (37) and maintains genome integrity. It was identified that associate with
H3K9 methylation, which is controlled by LSD1 and ESET/Setdb1(38), and H4K20
methylation.
Depletion of SMYD5 led to a downregulation in H4K20me3 levels, but not
H4K20me2

or

H4K20me1,

demonstrating

that

SMYD5

endows

H4K20me3

methyltransferase activity. Overexpressing a shRNA-resistant version of wild-type
SMYD5 restored the level of H4K20me3. Knockdown of SMYD5 also reduced levels of
H3K9me2/3 and HP1α. Because H4K20me3 is reported to co-localize with H3K9me3 at
heterochromatic regions (5,39) and H3K9me3 is necessary for recruitment of HP1 and
heterochromatin formation, it is possible that delocalization of HP1 and H3K9me3,
depending upon the lacking of SMYD5 and H4K20me3, may tend to reduced
heterochromatin.
Overall, a loss of SMYD5, which silence heterochromatin adjacent genic domains,
results in increased expression of lineage-specific genes, contributing to the decreased selfrenewal and disturbed differentiation of SMYD5-kockdown ES cells.(35)
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1.3.2 SMYD5 regulate hematopoiesis in zebrafish embryos
Unlike SMYD1-4, Smyd5 is not required for heart and skeletal muscle
development. Knockdown of SMYD5 in zebrafish embryo showed no abnormality (Figure
7)(32).

Figure 7: Knockdown of smyd5 results in normal growth of zebrafish embryo, including heart
and skeletal muscle. (32)

Also, the gene expression patterns of cardiac and myogenic markers, the structure
of sarcomere of heart, fast-and-slow skeletal muscle were indistinguishable between
control embryo and knock down embryo(32). These results indicate that SMYD5 has
physiological functions which are distinct from those played by the other members.
With the goal of defining the function of Smyd5 in zebrafish, scientists focused on
the development of hematopoietic cells, derived from the mesoderm as heart and skeletal
muscle. Hematopoietic cells generate blood cells of all lineages through the process
of hematopoiesis. Similar to the other vertebrates, zebrafish hematopoiesis has two stages,
primitive and definitive hematopoiesis(40).
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To investigate the role of SMYD5, they tested the expression of genes related to
hematopoiesis by performing a method of whole-mount in situ hybridization (WISH), to
detect the target gene expression in the whole embryo. When knockdown of SMYD5, the
expression of pu.1, mpx, l-plastin (Figure 8) increased during primary state and mpx, lplastin, cmvb(Figure 9) increased during definitive state (32). The elevated expression of
myeloid markers in SMYD5 loss-of-function zebrafish embryo, suggests that SMYD5
negatively regulates the expression of genes related to primitive and definitive
myelopoiesis in zebrafish.
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Figure 8: Expression of markers for primitive hematopoietic lineages in smyd5 morphants by
WISH(32)

Figure 9: Expression of markers for definitive hematopoietic lineages in smyd5 morphants by
WISH.(32)

18

1.3.3 SMYD5 in Cancer
SMYD5 was reported to involve in breast cancer, the most common among women
and the second most frequent cancer worldwide.
In the present study, people explored the expression profile of SMYD5 in breast
tumors and contiguous non-tumor samples, in breast cancer cells and some normal tissues.
qPCR revealed expression level of SMYD5 was decreased in 7 breast cancer cell lines
comparing to normal breast tissues. These findings led them to investigate the role of
SMYD5 in cell proliferation. They observed that downregulation of SMYD5 expression
through shRNA in HEK293 cells induced culture growth acceleration.(41)
Furthermore, the generation of MDA-MB-231 tumor cell sublines expressing
different levels of SMYD5 revealed varying proliferative profiles. SMYD5 expression
oppositely related with growth rate in highly proliferative cultures but slow proliferating
cells do not seem to be altered by SMYD5 levels. This observation shows that specific
subgroup of highly proliferative cells might depend on SMYD5 downregulation to display
this phenotype. (41)
However, another study revealed that SMYD5 inhibited the capacity of metastatic
breast cancer cells to colonize the lung.(42)
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Figure 10: ErbB2-TGL cells stably transduced
with empty vector or the indicated genes
(Numb, Left; Smyd5, Right) were inoculated i.v.
into syngeneic mice. Lung metastasis was
measured by bioluminescent imaging. The panels
show representative images (Top), and the graphs
show the normalized photon flux at the indicated
times (Bottom). (42)
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1.4 Statement of Hypothesis
Biological roles of SMYD5 have started to emerge in the area of immune reaction,
embryonic stem cell regulation, hematopoiesis regulation, and cancer inhibition, but the
biochemical and structural features needed to facilitate SMYD5 mediated methylation of
histone H4, as well as other potential substrates, has not been clearly explored.
The lacking of C-terminal TPR domain makes SMYD5 different from the other
protein members while a poly-E region (Figure 11) at the end of C-terminal draw our
attention, which tends to associate with metal ions, like calcium.

Figure 11: hSMYD5 poly-E region(19)

Figure 12: hSMYD5 mitochondrial targeting sequence

Moreover, we found that SMYD5 contains a mitochondrial targeting sequence
(Figure 12) at the N-terminal indicating that SMYD5 could potentially be a mitochondrial
protein. It is well-known that mitochondria is a calcium sensor which confirmed our
assumption about the relation between SMYD5 poly-E tail and calcium ions. According to
these, we assuming that SMYD5 might be a mitochondrial protein and its poly-E tail could
associate with calcium thus affect the enzymatic activity of SMYD5.
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Hypothesis:


Crystal structure would provide better view of its specific biochemical

function and structural features.


SMYD5 has a potential to be a mitochondrial protein.



The poly-E tail of SMYD5 might affect protein activity.

Aims:


Overexpression of SMYD5 in E.coli.



Obtain purified SMYD5 to perform biochemical and structural studies.



Determine the crystal structure of SMYD5 by using X-ray crystallography.



Characterize the enzymatic activity of methyltransferase SMYD5.
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CHAPTER 2: SMYD5 Molecular cloning and
expression
To perform biochemical and structural studies, the protein preparation must be
pure and homogeneous, molecular cloning and expression are inevitable processes to get
purified SMYD5 protein.

2.1 Molecular cloning
2.1.1 Material and Method
To get human SMYD5 gene, DH10B cells were purchased from the Open
Biosystem company. Gene accession number is BC073806 (Table 3), and a fulllength open frame sequence of SMYD5 is 1254 base pairs (bp). SMYD5 gene was
in the POTB7 vector. To create a plasmid that SMYD5 gene will be inserted in
pCDF-SUMO vector (Figure 13), primers were designed to curtail the interest gene
from its original vector by PCR.

Figure 13: pCDF-SUMO vector map
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5' primer length is 36 bp, GTATAAGAAGACATAGGTATGGCGGCCTCCATG
TGC(Tm=64.5ºC), included a BbsⅠ restriction site. 3' primer is 33 bp, CAC
GCCTCGAGTTACACATCAGTCATCTCATC

(Tm=63.6ºC),

included

a

XhoⅠ

restriction site. Ordered primer from Invitrogen Company.

Table 3: human SMYD5 DNA sequence

CDS:
>gi|154689857:30-1286 Homo sapiens SMYD family member 5 (SMYD5), mRNA
ATGGCGGCCTCCATGTGCGACGTGTTCTCCTTCTGCGTGGGCGTGGCGGGCCGCGCGCGGGTCTCCGTGG
AAGTCCGTTTCGTGAGCAGCGCCAAGGGAAAGGGGCTGTTTGCCACACAGCTCATCCGGAAGGGGGAGAC
CATCTTCGTAGAACGGCCCCTGGTGGCTGCACAGTTTCTCTGGAATGCACTTTATCGCTACCGAGCCTGT
GACCACTGCCTTAGGGCACTAGAGAAGGCAGAGGAGAATGCCCAGAGGCTGACCGGGAAACCAGGCCAGG
TTCTGCCTCACCCAGAGCTGTGCACTGTGCGCAAAGACCTCCACCAGAACTGTCCCCATTGCCAAGTGAT
GTACTGCAGTGCAGAATGTCGGTTGGCAGCCACTGAGCAATACCACCAGGTCCTGTGCCCAGGCCCCTCC
CAGGATGACCCCTTGCATCCTCTCAATAAGCTTCAGGAGGCATGGAGGAGTATTCACTACCCACCTGAGA
CTGCAAGCATCATGTTGATGGCTAGGATGGTGGCCACAGTGAAGCAGGCGAAGGACAAGGACCGTTGGAT
CAGACTCTTTTCCCAGTTTTGTAACAAAACAGCCAATGAAGAGGAGGAAATTGTCCATAAACTTCTGGGA
GACAAATTCAAGGGCCAACTGGAACTTCTGCGGAGACTCTTCACAGAGGCCCTCTATGAGGAAGCAGTCA
GCCAGTGGTTCACTCCAGATGGATTCCGGTCTCTCTTTGCTCTTGTTGGGACCAATGGCCAAGGAATCGG
GACCAGCTCCCTAAGCCAGTGGGTCCATGCCTGTGACACTCTGGAGTTGAAGCCTCAGGACCGTGAGCAG
CTTGACGCCTTCATTGACCAGCTATACAAGGACATCGAGGCAGCAACTGGAGAGTTTCTTAACTGTGAAG
GATCTGGCCTCTTTGTGCTTCAGAGCTGCTGCAACCACAGTTGTGTGCCCAATGCAGAGACCTCCTTTCC
AGAAAACAACTTCCTTTTGCATGTCACTGCTCTGGAGGATATTAAGCCAGGAGAGGAAATTTGTATCAGC
TACTTGGACTGCTGTCAGCGGGAGCGCAGCCGCCACAGCCGCCACAAGATCCTCAGGGAGAACTATCTAT
TTGTCTGTTCCTGTCCCAAATGCCTGGCAGAGGCTGATGAACCCAATGTGACCTCAGAAGAGGAAGAGGA
AGAGGAGGAGGAGGAGGAAGGAGAGCCAGAAGATGCAGAGCTGGGGGATGAGATGACTGATGTGTGA
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M

POTB7-SMYD5

M

A

1

2

3

B

3k

3k
2k
1.5k
1k

0.5k

0.5k

Figure 14: 0.8% Agarose gel (A) SMYD5 gene in POTB7 vector, bands located as expected
(B) SMYD5 gene PCR product. 1/2/3 indicated 2Mm/3Mm//4Mm MgCl2

First, SMYD5 commercial plasmid is going to transferred into DH5α cell and
saving as glycerol stock. DH10B cells grew in 5ml LB media contains 34 µg/mL
chloramphenicol at 37 ºC overnight. The clones were purified by mini prep kit (Qiagen
Company) and got purified POTB7-SMYD5 plasmid. Product was analyzed on a 0.8%
agarose gel for 30mins at 100V to check the size, which should be around 3k as the size of
SMYD5 is 1254 bp and POTB7 vector length is 1815 bp (Figure 14). 1.0 ng of vector was
transformed into 20 µL of DH5α cells and heat shocked for 45 seconds at 42˚C. Then, a
250µL volume of warm SOC medium was added and transformed cells were shaken for
1hour. Next, 50µL volume of transformed cells were plated onto chloramphenicol resistant
LB Agar plates. LB plates were grown overnight at 37˚C. One single colony was selected
and grew in in 5mL LB media contains 34 µg/mL chloramphenicol at 37 ºC overnight.
DH5α culture was aliquoted into 1mL with 300 µL glycerol in 2ml coring tubes, saved in
-80 ºC for future use.
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Secondly, SMYD5 gene is going to be inserted into pCDF-SUMO vector in DH5α
cells. SMYD5 gene was amplified through PCR, then analyzed on a 0.8% agarose gel for
30mins at 100V to check the PCR product size (Figure 14). The bands were at the expected
position. PCR product was purified using PCR clean up kit (Qiagen Company) and
SMYD5 gene was obtained as an insert fragment. 2 restriction enzymes and their buffer
were added into SMYD5 tube and vector tube respectively, 2 tubes were incubated for 1
hour at 37 ºC to let enzyme cut the sequences at restriction site to reveal the sticky ends
(Figure 15).Then a 0.8% agarose "blue gel" contained crystal violet was made to use, which
can stain DNA in the gel to make it visible to naked eyes, result in preventing DNA from
UV damage of the imager. Both insert and vector were loaded on the gel, run for 30mins
at 100V, and needed DNA segments were cut out from the gel. Gel pieces were placed in
separate tubes and mass the segments, then genes were extracted from blue gel using gel
extraction kit (Qiagen Company). Purified insert and purified vector were mixed with quick
ligase and buffer, incubated at room temperature for 7mins then all ingredients were added
into 20 µL DH5α cells. Transformation was performed using heat-shock method,
transferring SMYD5-pCDF-SUMO plasmid into cells. Then, a 250µL volume of warm
SOC medium was added and transformed cells were shaken for 1hour. Next, 100µL
volume of transformed cells were plated onto streptomycin resistant LB Agar plates. LB
plates were grown overnight at 37˚C. 3 colonies were selected and grew in in 5mL LB
media contained 100 µg/mL streptomycin at 37 ºC overnight. Cell culture of each colony
was aliquoted into 1mL with 300 µL glycerol in 2ml coring tubes, saved in -80 ºC for future
use. The left clones were purified by mini prep kit (Qiagen Company). Plasmid samples
were sent to Genewiz Company for sequence.
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Figure 15: Molecular cloning mechanism

2.1.2 Molecular Cloning Result
SMYD5 gene was successfully inserted into pCDF-SUMO vector. According to
the sequencing result (Table 4), this clone contains one silent mutant 132EE
(GAGGAA), which raises the usage in E.coli. Conclusively, the SMYD5 gene was
successfully cloned into the pCDF-SUMO vector and this plasmid can be used for the
continuous experiment.

Table 4 Human SMYD5 sequencing result (pCDF-SUMO vector)
5'-3'
Query

76

ATGGCGGCCTCCATGTGCGACGTGTTCTCCTTCTGCGTGGGCGTGGCGGGCCGCGCGCGG

135

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

1

ATGGCGGCCTCCATGTGCGACGTGTTCTCCTTCTGCGTGGGCGTGGCGGGCCGCGCGCGG

60
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Query

136

GTCTCCGTGGAAGTCCGTTTCGTGAGCAGCGCCAAGGGAAAGGGGCTGTTTGCCACACAG

195

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

61

GTCTCCGTGGAAGTCCGTTTCGTGAGCAGCGCCAAGGGAAAGGGGCTGTTTGCCACACAG

120

Query

196

CTCATCCGGAAGGGGGAGACCATCTTCGTAGAACGGCCCCTGGTGGCTGCACAGTTTCTC

255

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

121

CTCATCCGGAAGGGGGAGACCATCTTCGTAGAACGGCCCCTGGTGGCTGCACAGTTTCTC

180

Query

256

TGGAATGCACTTTATCGCTACCGAGCCTGTGACCACTGCCTTAGGGCACTAGAGAAGGCA

315

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

181

TGGAATGCACTTTATCGCTACCGAGCCTGTGACCACTGCCTTAGGGCACTAGAGAAGGCA

240

Query

316

GAGGAAAATGCCCAGAGGCTGACCGGGAAACCAGGCCAGGTTCTGCCTCACCCAGAGCTG

375

||||| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

241

GAGGAGAATGCCCAGAGGCTGACCGGGAAACCAGGCCAGGTTCTGCCTCACCCAGAGCTG

300

Query

376

TGCACTGTGCGCAAAGACCTCCACCAGAACTGTCCCCATTGCCAAGTGATGTACTGCAGT

435

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

301

TGCACTGTGCGCAAAGACCTCCACCAGAACTGTCCCCATTGCCAAGTGATGTACTGCAGT

360

Query

436

GCAGAATGTCGGTTGGCAGCCACTGAGCAATACCACCAGGTCCTGTGCCCAGGCCCCTCC

495

Sbjct

361

GCAGAATGTCGGTTGGCAGCCACTGAGCAATACCACCAGGTCCTGTGCCCAGGCCCCTCC

420

Query

496

CAGGATGACCCCTTGCATCCTCTCAATAAGCTTCAGGAGGCATGGAGGAGTATTCACTAC

555

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

421

CAGGATGACCCCTTGCATCCTCTCAATAAGCTTCAGGAGGCATGGAGGAGTATTCACTAC

480

Query

556

CCACCTGAGACTGCAAGCATCATGTTGATGGCTAGGATGGTGGCCACAGTGAAGCAGGCG

615

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

481

CCACCTGAGACTGCAAGCATCATGTTGATGGCTAGGATGGTGGCCACAGTGAAGCAGGCG

540

3'-5'
Query

87

ACACATCAGTCATCTCATCCCCCAGCTCTGCATCTTCTGGctctccttcctcctcctcct

146

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

1255

ACACATCAGTCATCTCATCCCCCAGCTCTGCATCTTCTGGCTCTCCTTCCTCCTCCTCCT

1196

28

Query

147

cctcttcctcttcctcttctGAGGTCACATTGGGTTCATCAGCCTCTGCCAGGCATTTGG

206

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

1195

CCTCTTCCTCTTCCTCTTCTGAGGTCACATTGGGTTCATCAGCCTCTGCCAGGCATTTGG

1136

Query

207

GACAGGAACAGACAAATAGATAGTTCTCCCTGAGGATCTTGTGGCGGCTGTGGCGGCTGC

266

Sbjct

1135

GACAGGAACAGACAAATAGATAGTTCTCCCTGAGGATCTTGTGGCGGCTGTGGCGGCTGC

1076

Query

267

GCTCCCGCTGACAGCAGTCCAAGTAGCTGATACAAATTTCCTCTCCTGGCTTAATATCCT

326

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

1075

GCTCCCGCTGACAGCAGTCCAAGTAGCTGATACAAATTTCCTCTCCTGGCTTAATATCCT

1016

Query

327

CCAGAGCAGTGACATGCAAAAGGAAGTTGTTTTCTGGAAAGGAGGTCTCTGCATTGGGCA

386

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

1015

CCAGAGCAGTGACATGCAAAAGGAAGTTGTTTTCTGGAAAGGAGGTCTCTGCATTGGGCA

956

Query

387

CACAACTGTGGTTGCAGCAGCTCTGAAGCACAAAGAGGCCAGATCCTTCACAGTTAAGAA

446

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

955

CACAACTGTGGTTGCAGCAGCTCTGAAGCACAAAGAGGCCAGATCCTTCACAGTTAAGAA

896

Query

447

ACTCTCCAGTTGCTGCCTCGATGTCCTTGTATAGCTGGTCAATGAAGGCGTCAAGCTGCT

506

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

895

ACTCTCCAGTTGCTGCCTCGATGTCCTTGTATAGCTGGTCAATGAAGGCGTCAAGCTGCT

836

Query

507

CACGGTCCTGAGGCTTCAACTCCAGAGTGTCACAGGCATGGACCCACTGGCTTAGGGAGC

566

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

835

CACGGTCCTGAGGCTTCAACTCCAGAGTGTCACAGGCATGGACCCACTGGCTTAGGGAGC

776

Query

567

TGGTCCCGATTCCTTGGCCATTGGTCCCAACAAGAGCAAAGAGAGACCGGAATCCATCTG

626

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

775

TGGTCCCGATTCCTTGGCCATTGGTCCCAACAAGAGCAAAGAGAGACCGGAATCCATCTG

716

Query

627

GAGTGAACCACTGGCTGACTGCTTCCTCATAGAGGGCCTCTGTGAAGAGTCTCCGCAGAA

686

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

715

GAGTGAACCACTGGCTGACTGCTTCCTCATAGAGGGCCTCTGTGAAGAGTCTCCGCAGAA

656

Query

687

GTTCCAGTTGGCCCTTGAATTTGTCTCCCAGAAGTTTATGGACAATTTCCTCCTCTTCAT

746

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

655

GTTCCAGTTGGCCCTTGAATTTGTCTCCCAGAAGTTTATGGACAATTTCCTCCTCTTCAT

596

29

Query

747

TGGCTGTTTTGTTACAAAACTGGGAAAAGAGTCTGATCCAACGGTCCTTGTCCTTCGCCT

806

||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sbjct

595

TGGCTGTTTTGTTACAAAACTGGGAAAAGAGTCTGATCCAACGGTCCTTGTCCTTCGCCT

536

2.2 Protein Expression
2.2.1 Material and Method
First, SMYD5 plasmid is going to be transferred into host cell BL21 for protein
expression. Once the co-construct vector was obtained, 1.0 ng of vector was transformed
into 20µL of codon optimized BL21 cells and heat shocked for 45 seconds at 42˚C. Then,
a 250µL volume of warm SOC medium was added and transformed cells were shaken for
1hour. Next, 100µL volume of transformed cells were plated onto streptomycin resistant
LB Agar plates. LB plates were grown overnight at 37˚C. 1 colony was selected and grew
in 5mL LB media contained 100 µg/mL streptomycin at 37 ºC overnight. BL21 cell culture
was aliquoted into 1 mL with 300 µL glycerol in 2mL coring tubes, saved in -80 ºC for
future use.
Second, a small scale and a large scale protein expression test is performed. 30µL
BL21 overnight cell culture was added into 3mL fresh LB media, then growth continued
at 37 ºC once the pre-induction OD600 reached 0.4-0.6. A 1.0 mL volume of culture was
saved to test for non-induced expression and the remaining culture was slowly cool down
to 15 ºC, sat for half hour, and induced with 0.1 mM IPTG. Induced culture was grown for
20-22 hours at 15˚C and collected for SDS-PAGE. Cells were sonicated and centrifuged to

30

make supernatant and pellet samples to test protein solubility. Samples were analyzed on
15% SDS-PAGE.
Large scale test is an 100 times amplification of small scale test. 5mL overnight
BL21 culture was added into 500mL fresh LB media, then growth continued at 37 ºC once
the pre-induction OD600 reached 0.4-0.6. A 1.0 mL volume of culture was saved to test
for non-induced expression and the remaining culture was slowly cool down to 15 ºC, sat
for half hour, and induced with 0.1 mM IPTG. Induced culture were grown for 20-22 hours
at15˚C and collected for SDS-PAGE (Figure 16). Cells were French pressed to get cell
lysate for purification.
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Figure 16 : 15% SDS-page of large scale protein expression test
"UnI"-un-induced cell, "Ind"-induced cell, "T"-total cell lysate, "S"-supernatant of cell lysate
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CHAPTER 3: SMYD5 Purification
3.1

Material and Method

3.1.1 Purification Strategy
The SUMO protein has a His tag which can bind to the His-trap nickel column
agarose matrix (GE Company). Loading cell lysate on the 1st Ni column and SUMOSMYD5 bound to the column because of the SUMO His tag (Figure 17). However,
imidazole is part of the structure histidine binding to Ni ions and it competes with His for
Ni binding sites (Figure 17).

B

A

Figure 17: Histidine (A) and Imidazole (B) binds to Ni

Low concentration of imidazole prevents the non-specific and low affinity binding
of background protein. After washing with low concentration imidazole buffer, SUMOSMYD5 protein was eluted out by high concentration of imidazole buffer.
SUMO protease was added to cut protein at 4 ºC overnight. As protein is in elution
buffer, next step is using desalting column to replace the elution buffer with binding buffer.
When load protein samples, which have been cut, on the 2nd his trap, SMYD5 directly
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passed through the Ni column whereas sumo protein bound to the column. Eventually, gel
filtration column separates protein based on size (Figure 18). Larger proteins were eluted
earlier while smaller proteins were eluted later and provide a better resolution.

Figure 18 Gel filtration Column Mechanism

Figure 19: Overview of SUMO-SMYD5 purification strategy
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3.1.2 Buffer preparation
Binding buffer - 20 mM Tris, pH7.4, 0.5 M NaCl, 20 mM imidazole, 5% glycerol,
5 mM BME; Elution buffer - 20 mM Tris, pH7.4, 0.5 M NaCl, 500 mM Imidazole, 5%
glycerol, 5 mM BME; Gel Filtration Buffer - 20mM Tris pH8.0, 150 mM NaCl, 5%
glycerol, 5mM BME. All the buffers were filtered and degassed.

3.2 Purification Result
3.2.1 1st Ni column
In the chromatogram (Figure 20), the green line represents continuous flow
of increasing imidazole, (20mM/500mM) and the blue line represents the UV
absorbance of eluted protein. The first peak indicated washed out heat-shock
protein 70 with weak binding affinity to nickel column, and the second peak clearly
showed SUMO-SMYD5 protein was eluted out, which is also shown on the SDSPAGE gel (Figure 21), Fractions A9-B2 were pooled together. 15 µL SUMO
protease was added into collection and incubated at 4 ºC overnight to cut SUMO
protein off.
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Figure 20: SUMO-SMYD5 Purification 1st Ni Column. 1st Peak-HSP 70, 300 mAU, eluted by
28% elution buffer. 2nd peak-SUMO-SMYD5, 471 mAU, eluted by 40% elution buffer.
M
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66.4
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Figure 21: 15%SDS-PAGE of SUMO-SMYD5 Purification 1st Ni Column
"1st L"-1st Ni Column Loading, "FT"- Flow Through

B3 B5 B8
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3.2.2 Desalting column
The desalting column is used to separate soluble macromolecules from
smaller molecules or replace the buffer system. Proteins flow pass the beads, salts
and small molecules flow through the beads so proteins flow faster through the
column. In the chromatogram (Figure 22), there was only one peak. According to
this UV absorbance, fractions A5-B1 were collected, and analyzed on the 15% SDS
gel (Figure 23)

Figure 22: SUMO-SMYD5 Purification Desalting Column.Peak:1200mAU.
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Figure 23: 15%SDS-PAGE of SUMO-SMYD5 Purification Desalting Column
"B.C"-before cut, "A.C"-after cut, "D.L"-desalting load, "D.FT"-desalting flow through, "D.P"desalting pool
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3.2.3 2nd Ni column
After desalting column and incubation with SUMO protease, SMYD5 and
SUMO protein were separated in the binding buffer system. When loading the
sample on the 2nd Ni column, SMYD5 directly passed column while SUMO
protein bound to Ni column because of the His tag. SMYD5 was collected in the
flow through fraction and SUMO protein was washed out by elution buffer (Figure
24).

Figure 24: SMYD5 Purification 2nd Ni Column Elution.
1st peak-HSP 70, eluted by 28% elution buffer. 2nd peak-SUMO protein, eluted by 41% elution
buffer.
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3.2.4 Gel filtration column
SMYD5 was concentrated to 1mL, and loaded on gel filtration column. According
to the gel filtration standard (Figure 25), the elution volume 79ml was consistent with
SMYD5 molecular weight 47kDa (Figure 26). Also the bands on SDS-PAGE were on the
expected position (Figure 27). Fractions B5-B10 were collected. SMYD5 protein was
filtered and concentrated. 1.35mg purified SMYD5 protein was obtained.

Figure 25: Gel filtration standard

Figure 26: SMYD5 Purification Gel Filtration Column.
1st peak-void peak. 2nd peak-SMYD5, 54mAU, eluted at 79ml.
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Figure 27 : 15% SDS-PAGE of SMYD5 Purification Gel Filtration Column."B.C"-before
concentration, "A.C"-after concentration, "G.L"-gel filtration load.
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CHAPTER 4: GST-SMYD5 Molecular Cloning,
Expression and Purification
In order to get more variable references in SMYD5 activity assay, GST-SMYD5
purification was performed.

4.1 Molecular Cloning
Clone human SMYD5 gene into pGEX-6P-2 vector (Figure 28).

4.1.1 Material and Method

Figure 28: pGEX-6P-2 vector map

The whole procedure was basically as same as the approach of cloning SUMOSMYD5.
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Size of 5' primer is 33 bp, TACTTAGGATCCATGGCGGCCTCCATGTGCGAC
(Tm=68.1ºC), included a BamHⅠ restriction site. Size of 3' primer is 33 bp, CAC
GCCTCGAGTTACACATCAGTCATCTCATC

(Tm=63.6ºC),

included

an

XhoⅠ

restriction site. Ordered primer from Invitrogen Company.

4.1.2 Molecular Cloning Result
SMYD5 gene was successfully inserted into pGEX vector, and no mutant occurred.

4.2 Expression
Since the GST-SMYD5 is 76kDa, bigger than 60kDa, lower percentage SDSPAGE was selected to promote the 66-212 kDa range protein separation (Figure 29).
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Figure 29: 12% SDS-PAGE of GST-SMYD5 expression test. "UnI"-un-induced cell,"Ind"induced cells, "T"-total cell lysate, "S"-supernatant of cell lysate
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4.3 Purification
4.3.1 Purification strategy
The purification strategy is based on the high affinity of GST for glutathione (Figure
30). To let GST tagged protein bind to matrix, we choose the condition that favor

interaction of the GST with the glutathione column which is around PH7.5. Therefore,
binding buffer should be between PH 7.2-7.5. When sample was applied to the affinity
matrix, GST fusion proteins bound to the glutathione ligand, and impurities were removed
by washing with binding buffer. When column was washed with a PH8.5 elution buffer
contained glutathione, tagged proteins were eluted from the chromatography resin under
mild, non-denaturing conditions that preserve both protein structure and function.

Figure 30: GST-SMYD5 Purification strategy
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4.3.2 Buffer preparation
Binding buffer-50mM Tris pH 7.5, 200mM NaCl, 1mM EDTA, 1mM BME, 5%
glycerol. Elution buffer-50mM Tris pH 8.5, 500mM NaCl, 1mM EDTA, 1mM BME, 5%
glycerol, 10mM reduced glutathione. Gel Filtration Buffer-20mM Tris pH 8.0, 150 mM
NaCl, 5% glycerol, 5mM BME. All the buffer was filtered and degassed.

4.3.3 Purification result
4.3.3.1

GST-trap column

GST-SMYD5 was eluted out quickly (Figure 31). GST-SMYD5 protein didn't show
either in the flow through or wash according to the SDS-PAGE analysis.

Figure 31: GST-SMYD5 purification GST-trap column. Peak-GST-SMYD5:350mAU.
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Figure 32: 12%/15% SDS-PAGE OF GST-SMYD5 purification.
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"G.L"-GST-trap load, "FT"-flow through, "D.L"-desalting load, "D.F.T"-desalting flow
through", "Con"-concentrated, "Con"-concentration flow through

4.3.3.2

Desalting column
Desalting column replaced GST elution buffer by gel filtration buffer
(Figure 33).
1.6mg purified GST-SMYD5 protein was obtained.

Figure 33: GST-SMYD5 purification desalting column
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CHAPTER 5: SMYD5 Protein Analysis
5.1 Crystal Structure
Sequence alignment of SMYD5 with the other members of the SMYD family
revealed several structural differences not found in the sequences of the other SMYD
proteins. These observations indicate that SMYD5 recognizes its substrate using divergent
structural determinants comparing to SMYD1-3. Obtaining a crystal structure of SMYD5
would reveal how these differences translate into specificity.

5.1.1 Material and Method
There are 2 common methods used in crystal screening, sitting drop and hanging
drop (Figure 34), sharing the same principle which is the sample drop contains a lower
reagent concentration than the reservoir. Water vapor leaves the drop and finally ends up
in the reservoir to achieve equilibrium. Because water leaves the drop, the sample
experiences an increase in relative supersaturation. Both the sample concentration and
reagent concentration increase because water leaves the drop for the reservoir.
Sitting drop vapor diffusion: Time efficient. • Often easier when using detergents,
organics and hydrophobic reagents. • Drops can be positioned in a stable sitting spot.
Hanging drop vapor diffusion: Easy access to crystals. • Could perform multiple
drops with a single reservoir.

Sitting drop

Hanging drop

Figure 34: Sitting drop & Hanging drop
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5.1.2 Result
During the approach to crystalize SMYD5, several promising conditions (Figure 35)
were achieved in hundred contentions. To check the protein quality, SMYD5 protein
samples were prepared to run on a 6% native gel. After staining by Coomassie blue, an
additional upper band occurred (Figure 35). We assumed that the band might be a protein
dimer formed by non-specific disulfide bonds. Therefore, some reducing agent were added
to SMYD5 samples as reducing agent could break the bonds. An observation that the bands
were removed by high concentration reducing agent confirmed the speculation that the
band might be protein dimer formed by non-specific disulfide bonds.
More crystal screens were set up with conditions contained 50mM DTT. After
introducing DTT, some previous precipitate conditions turned into clean or light
precipitate. These phenomena suggested that high concentration DTT may increase protein
solubility. Although crystallization of SMYD5 has not been successful, increasing DTT
concentration may promote protein solubility and facilitate chance of crystallization.

A

B

Figure 35: Crystal screen analysis.(A)promising crystal screen condition: face separation.(B)6%
native gel of SMYD5 protein
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5.2 SMYD5 Methyltransferase Activity Assay
The reason why SMYD5 is unique, is not only about lacking of C-terminus
TPR domain, but also the additional poly-glutamate stretch tail (
Figure 36),

which brings more negative charge to SMYD5.

Figure 36: poly-E region of SMYD5 sequence

On other hand, SMYD5 has a potential to be a mitochondria protein, as it contains
a mitochondria targeting sequence (Table 5) at the N-terminus, which consists of an
alternating pattern of hydrophobic and positively charged amino acids to form an
amphipathic helix, which direct a newly synthesized protein to the mitochondria.
Table 5: mitochondria targeting sequence
10

20

30

40

50

MAASMCDVFS FCVGVAGRAR VSVEVRFVSS AKGKGLFATQ LIRKGETIFV

Moreover, as we all know, mitochondria functions as a calcium sensor and this
poly-E region shows a potential of binding to Calcium as well. According to our predict
structure, this region is close to SMYD5 C-terminal active site. Overall, we assumed that
this poly-E region might effect S5 activity if it binds to calcium ion.
An antibody based activity assay (western blot) was performed to test SMYD5
enzymatic activity.
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5.2.1 Material and Method
SMYD5 activity assay were carried out in methyltransferase reaction buffer, with
histone H4 and SAM, incubated at 30 °C overnight. Reactions were stopped with the
addition of SDS-PAGE loading buffer and boiled for 5 minutes, then were separated by
SDS-PAGE. Proteins were transferred to nitrocellulose membrane using wet tank transfer
method (Bio-rad), at 4°C 100V for1hour.
Membrane was incubated in 2%BSA or milk for 1hour, washed with 0.0.5% TBST
buffer 2 *5 mins then gently shaken in primary antibody anti-tri-methylated lysine (1:1000,
Abcam) at 4°C overnight. Then membrane was washed with 0.0.5% TBST for 3 *5 mins.
Second incubation was shaking membrane in secondary antibody Goat-anti rabbit for 12hours. After this, membrane was washed again with 0.0.5% TBST buffer 3 *5 mins.
ECL reagent was added equably on the whole membrane to expose membrane in
the dark room of UV imager.
Reaction buffer conditions were tested using 2mg/4mg/10mg SMYD5, 5mg GSTSMYD5 with 1mg/1.5mg/2mg histone H4, 50mM/100mM/200mM SAM in 50mM buffer
(Tris

pH

7.5,

8.0

and

9.0,

Bicine

pH

9.0)

with

0.5mM/50mM/DTT,

0.1Mm/0.5mM/1mM/5Mm/10mM EDTA, 5mM/25mM CaCl2, 5mM/25mM MgCl2,
25mM/50mM/100mM NaCl, 5%/25% Glycerol.

5.2.2 Activity assay result
So far, no obvious signal has been observed from either SMYD5 or GST-SMYD5
in Tris buffer system. However, a weak signal showed in western blot result of Bicine
buffer reaction (Figure 37).
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A

B

Figure 37: Ponceau S staining and western blot result (exposure time 5 mins)of SMYD5 activity
test.(A)PH9.0 Tris buffer (B)PH 9.0 Bicine buffer
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CHAPTER 6: Discussion
After successful expression and purification of SMYD5, to characterize SMYD5
biochemical features, I expected to see what could enhance or repress SMYD5 enzymatic
activity. However, SMYD5 didn't show a strong enzymatic activity on either histone H4
or H4K20 peptide in comparison of SMYD3. I have raised several potentials.
First, the SMYD5 protein I purified lost activity during the purification. As we all
known, the matrix of His-trap column is Ni-agarose. Ni ions could be toxic to some
proteins, making them inactive. SMYD5 also could bind to some molecules or inhibitors
during the purification process. Therefore, we produced another construct, GST-SMYD5,
to avoid Ni-column during purification. Unfortunately, it didn't show a significant
difference from previous purified SMYD5.
Second, SMYD5 need some co-factor to activate. SAM is the donor of methyl
group in methylation reaction. The interact motif between SAM and SMYD5 still remain
unknown. It is feasible that SAM is required a co-factor to achieve the binding site of
SMYD5.
Third, SMYD5 is a context-substrate dependent enzyme. For example, respiratory
nitrate reductase complex (NarGHI) could exhibit two catalytically distinct forms of the
enzyme because of the influence of substrate, pH and inhibitors (43). Histone H4 was
reported as the first substrate of SMYD5 recently, and more related mechanisms need to
further explore.
However, according to the result I observed, the enzymatic activity of SMYD5 was
improved by Ca and Mg ions in Bicine buffer and the higher concentration of metal ions
provided a better result. This suggested that our hypothesis could be feasible and enabled
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a deeper investigation on SMYD5 associated with Ca and mitochondria. Additionally, the
predicted structure of SMYD5 (Figure 38) offered some clues. Although there is no
predicted structure of SMYD5 poly-E tail so far, the last residue before it leans towards to
the SET domain and remain close to the active site, raising a potential of altering the
enzymatic activity of SMYD5.

Figure 38: Predicted structure of SMYD5 (19-391). Yellow-SET domain, Blue-MYND domain,
Green-C-terminal domain, Red-the last residue before poly-E tail.
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CHAPTER 7: Future Direction
•

Incubate peptides with SMYD5 to applied in crystal screens or develop fusion

linker protein construct to facilitate crystallization of SMYD5
•

Perform more crystal screens containing DTT and SAM or other cofactors

•

Truncate poly-E tail of SMYD5 to test methyltransferase activity

•

Explore more substrates of SMYD5 protein

•

Investigate subcellular localization of SMYD5 to reveal its association with

mitochondria
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ABSTRACT
Expression, Purification and Characterization of Lysine Methyltransferase SMYD5
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Methylation of histones and non-histone proteins play vital roles in numerous
cellular processes including gene expression regulation and DNA damage response. The
identifications of methyltransferase SMYD protein family are not well characterized.
SMYD5 is a unique but critical member of SMYD family involved in immune response,
stem cell renew, hematopoiesis regulation and cancer metastasis. Understanding its
function and structure is monumental to human disease. With the achievement of SMYD5
expression and purification, the association between SMYD5 and its substrate histone H4
has been investigated. While possessing a poly-E tail instead of the TPR domain included
in other members, SMYD5 is assumed that associated with Calcium and could potentially
be a mitochondrial protein.
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